← Leaderboards
Srinivasa R Nagalla
Oregon Health And Science University
$1,916,601
Attributed
$1,916,601
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $543.9K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,916,601 · 6
By mechanism
R44$875,000 · 1
R43$838,930 · 3
R29$202,671 · 1
P30$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Hugo R Rosen$16,057,795
- Gary Thomas$15,359,735
- Michael J. Meredith$903,898
- Robert Frederick Klein$6,267,206
- Lynn M Marshall$512,978
Others in their field
Top investigators on “Incidence”
- Lawrence Corey · Fred Hutchinson Cancer Center$280,538,218
- David M Nathan · Massachusetts Institute Of Technology$138,375,637
- Sharon A Nachman · Johns Hopkins University$135,132,510
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$127,753,192
- James E. Gern · University Of Wisconsin-Madison$123,967,847
- John M Lachin · George Washington University$118,672,444
Research focus
IncidenceObesityDiagnosticImpaired CognitionMedicalNon-Insulin-Dependent Diabetes MellitusCostDiabetes MellitusFoundationsImmunoassayLateralLiquid SubstanceBaseMonitorChronicCohortDetectionDevicesEpidemicEye DiseasesHome EnvironmentCaringInflammatoryPersons
Grant awards (9)
NON-INVASIVE SALIVA-BASED DIABETES AUTOANTIBODY SCREENING.$291,375
R43 · FY2013 · DK · contact PI
NON-INVASIVE SALIVA-BASED DIABETES AUTOANTIBODY SCREENING.$291,375
R43 · FY2012 · DK · contact PI
NON-INVASIVE SALIVARY ASSESSMENT OF PREDIABETES AND DIABETES$149,822
R43 · FY2010 · DE · contact PI
Diagnostic proteomic profiles for aneuploidy$437,500
R44 · FY2006 · HD · contact PI
Biomarkers for prostate cancer risk assessment$106,358
R43 · FY2006 · CA · contact PI
Diagnostic proteomic profiles for aneuploidy$437,500
R44 · FY2005 · HD
XEN-DORPHINS--A NEW OPIOID SYSTEM$102,366
R29 · FY2001 · DA
XEN-DORPHINS--A NEW OPIOID SYSTEM$100,305
R29 · FY2000 · DA
Core--Gene discovery$0
P30 · FY2000 · CA